Remove Biomarkers Remove Diabetes Remove Obesity
article thumbnail

Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D

Med Page Today

(MedPage Today) -- ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 100
article thumbnail

Abstract TP268: Xylitol, Xylose, and MicroRNAs Associated with Thrombosis and the Clotting Cascade in a Multi-Omics Cross-Sectional Study of Adults at Risk for Type 2 Diabetes and Stroke

Stroke Journal

Older adults with obesity and metabolic syndrome may have decreased elimination of the xylitol metabolite xylose, which may explain the higher observed risk of thrombosis and stroke in older adults who consume foods with sugar alcohols. However, multiomics studies of both xylitol metabolites and these miRs in humans have not been done.

article thumbnail

Abstract WMP81: Overweight Patients Had Higher Odds of Favorable Outcome After Both Deep and Lobar Intracerebral Hemorrhage

Stroke Journal

Patients were divided into underweight, normal weight, overweight, and obese according to World Health Organization BMI criteria. Future biomarker studies are needed to better understand this relationship. There was no association between BMI and ICH volume in patients with deep or lobar hemorrhage. 7.34) and lobar (OR 3.15, 95% CI 1.67-5.94)

article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Aronne, MD , discussed advances in obesity pharmacology, while Virend K. Florez, MD, PhD , explored the future of precision medicine in diabetes. I am very inspired and rejuvenated at the 19th Annual CMHC.

CME 64
article thumbnail

Abstract 061: Identification of Proteins Predictive of Post?Thrombectomy Outcome Based on an Appalachian vs. Non?Appalachian Cohort

Stroke: Vascular and Interventional Neurology

Appalachians are more likely to have comorbidities related to stroke, such as diabetes, obesity, and tobacco use, and are often less likely to have stroke interventions such as mechanical thrombectomy (MT) for emergent large vessel occlusion (ELVO).

article thumbnail

Comparison of Atherosclerotic Cardiovascular Risk Factors and Cardiometabolic Profiles Between Current and Never Users of Marijuana

Circulation: Cardiovascular Quality & Outcomes

Current users (used within the past month) and never users were compared with assess the burden and control of traditional ASCVD risk factors and biomarkers, using inverse probability of treatment weighting to adjust for sociodemographic and lifestyle factors, including tobacco use.RESULTS:Of the 13 965 participants identified (mean age, 37.5;